| 1 | improvements | 13,658 |
| 2 | hypogyria | 6 |
| 3 | twis | 4 |
| 4 | 'changes | 3 |
| 5 | care-aides | 3 |
| 6 | digging | 3 |
| 7 | puerperants | 3 |
| 8 | yerberias | 3 |
| 9 | ag° | 2 |
| 10 | fa-alterations | 2 |
| 11 | pre-/post-change | 2 |
| 12 | qaly-gains | 2 |
| 13 | self-repairs | 2 |
| 14 | waypoints | 2 |
| 15 | 0/117 | 1 |
| 16 | 11,46 | 1 |
| 17 | 127/168 | 1 |
| 18 | 18f-fdg-uptake | 1 |
| 19 | 18t/18a | 1 |
| 20 | 2005-54-1781 | 1 |
| 21 | 2pns | 1 |
| 22 | 3.83-fold | 1 |
| 23 | 3.although | 1 |
| 24 | 317.74±60.23mosm | 1 |
| 25 | 5,5,11,11-tetracyano-5,11-dihydrotetracenes | 1 |
| 26 | 6,485,514 | 1 |
| 27 | 8-14weeks | 1 |
| 28 | a.marmelos | 1 |
| 29 | action-research | 1 |
| 30 | actrn12610000592044\ | 1 |
| 31 | adc-measurements | 1 |
| 32 | advatages | 1 |
| 33 | alrtis | 1 |
| 34 | araneus | 1 |
| 35 | c677tmutation | 1 |
| 36 | calcaneare | 1 |
| 37 | carbonitrile | 1 |
| 38 | cfrct | 1 |
| 39 | cocaine-choices | 1 |
| 40 | cyanotoxicity | 1 |
| 41 | cyclind-cdk4/6 | 1 |
| 42 | d-ds | 1 |
| 43 | decline/deterioration | 1 |
| 44 | decurarization | 1 |
| 45 | difference.laparoscopic | 1 |
| 46 | dizziness/nausea | 1 |
| 47 | duringfollow-up | 1 |
| 48 | dysfunctionments | 1 |
| 49 | dyslipldaemia | 1 |
| 50 | dysuria-frequency | 1 |
| 51 | ejy3 | 1 |
| 52 | estrones | 1 |
| 53 | fibre-bronchoscopy | 1 |
| 54 | gmhsps | 1 |
| 55 | hecatomb | 1 |
| 56 | hplc-microfractionation | 1 |
| 57 | htpr-phenotype | 1 |
| 58 | hyperadiponectinemia | 1 |
| 59 | hyperechoes | 1 |
| 60 | il13-pe38qqr | 1 |
| 61 | immaturities | 1 |
| 62 | immuno-stimulation | 1 |
| 63 | increament | 1 |
| 64 | insignificances | 1 |
| 65 | intestinum | 1 |
| 66 | jouanna | 1 |
| 67 | key-links | 1 |
| 68 | litigants | 1 |
| 69 | lncrease | 1 |
| 70 | lv-dyssynchrony | 1 |
| 71 | macrosclerotherapy | 1 |
| 72 | maternal-reduction | 1 |
| 73 | mfus | 1 |
| 74 | mu-modulations | 1 |
| 75 | n-pentane | 1 |
| 76 | nct01503762 | 1 |
| 77 | non-euvolaemia | 1 |
| 78 | perivascularly | 1 |
| 79 | physiological-based | 1 |
| 80 | post-handwashing | 1 |
| 81 | potassium-channels | 1 |
| 82 | pseudo-hyphae | 1 |
| 83 | put-analysis | 1 |
| 84 | pvmr | 1 |
| 85 | ras-mitochondria | 1 |
| 86 | reduiction | 1 |
| 87 | reimagined | 1 |
| 88 | rukararwe-bumetha | 1 |
| 89 | severeal | 1 |
| 90 | side-effects/mortality | 1 |
| 91 | solifenacin- | 1 |
| 92 | stabilization/improvements | 1 |
| 93 | strongpoint | 1 |
| 94 | teambuilding | 1 |
| 95 | thirty-day-mortality | 1 |
| 96 | tyr1143 | 1 |
| 97 | uv-modification | 1 |
| 1 | 'changes | 3 |
| 2 | 0/117 | 1 |
| 3 | 11,46 | 1 |
| 4 | 127/168 | 1 |
| 5 | 18f-fdg-uptake | 1 |
| 6 | 18t/18a | 1 |
| 7 | 2005-54-1781 | 1 |
| 8 | 2pns | 1 |
| 9 | 3.83-fold | 1 |
| 10 | 3.although | 1 |
| 11 | 317.74±60.23mosm | 1 |
| 12 | 5,5,11,11-tetracyano-5,11-dihydrotetracenes | 1 |
| 13 | 6,485,514 | 1 |
| 14 | 8-14weeks | 1 |
| 15 | a.marmelos | 1 |
| 16 | action-research | 1 |
| 17 | actrn12610000592044\ | 1 |
| 18 | adc-measurements | 1 |
| 19 | advatages | 1 |
| 20 | ag° | 2 |
| 21 | alrtis | 1 |
| 22 | araneus | 1 |
| 23 | c677tmutation | 1 |
| 24 | calcaneare | 1 |
| 25 | carbonitrile | 1 |
| 26 | care-aides | 3 |
| 27 | cfrct | 1 |
| 28 | cocaine-choices | 1 |
| 29 | cyanotoxicity | 1 |
| 30 | cyclind-cdk4/6 | 1 |
| 31 | d-ds | 1 |
| 32 | decline/deterioration | 1 |
| 33 | decurarization | 1 |
| 34 | difference.laparoscopic | 1 |
| 35 | digging | 3 |
| 36 | dizziness/nausea | 1 |
| 37 | duringfollow-up | 1 |
| 38 | dysfunctionments | 1 |
| 39 | dyslipldaemia | 1 |
| 40 | dysuria-frequency | 1 |
| 41 | ejy3 | 1 |
| 42 | estrones | 1 |
| 43 | fa-alterations | 2 |
| 44 | fibre-bronchoscopy | 1 |
| 45 | gmhsps | 1 |
| 46 | hecatomb | 1 |
| 47 | hplc-microfractionation | 1 |
| 48 | htpr-phenotype | 1 |
| 49 | hyperadiponectinemia | 1 |
| 50 | hyperechoes | 1 |
| 51 | hypogyria | 6 |
| 52 | il13-pe38qqr | 1 |
| 53 | immaturities | 1 |
| 54 | immuno-stimulation | 1 |
| 55 | improvements | 13,658 |
| 56 | increament | 1 |
| 57 | insignificances | 1 |
| 58 | intestinum | 1 |
| 59 | jouanna | 1 |
| 60 | key-links | 1 |
| 61 | litigants | 1 |
| 62 | lncrease | 1 |
| 63 | lv-dyssynchrony | 1 |
| 64 | macrosclerotherapy | 1 |
| 65 | maternal-reduction | 1 |
| 66 | mfus | 1 |
| 67 | mu-modulations | 1 |
| 68 | n-pentane | 1 |
| 69 | nct01503762 | 1 |
| 70 | non-euvolaemia | 1 |
| 71 | perivascularly | 1 |
| 72 | physiological-based | 1 |
| 73 | post-handwashing | 1 |
| 74 | potassium-channels | 1 |
| 75 | pre-/post-change | 2 |
| 76 | pseudo-hyphae | 1 |
| 77 | puerperants | 3 |
| 78 | put-analysis | 1 |
| 79 | pvmr | 1 |
| 80 | qaly-gains | 2 |
| 81 | ras-mitochondria | 1 |
| 82 | reduiction | 1 |
| 83 | reimagined | 1 |
| 84 | rukararwe-bumetha | 1 |
| 85 | self-repairs | 2 |
| 86 | severeal | 1 |
| 87 | side-effects/mortality | 1 |
| 88 | solifenacin- | 1 |
| 89 | stabilization/improvements | 1 |
| 90 | strongpoint | 1 |
| 91 | teambuilding | 1 |
| 92 | thirty-day-mortality | 1 |
| 93 | twis | 4 |
| 94 | tyr1143 | 1 |
| 95 | uv-modification | 1 |
| 96 | waypoints | 2 |
| 97 | yerberias | 3 |
| 1 | solifenacin- | 1 |
| 2 | 2005-54-1781 | 1 |
| 3 | nct01503762 | 1 |
| 4 | tyr1143 | 1 |
| 5 | ejy3 | 1 |
| 6 | 6,485,514 | 1 |
| 7 | cyclind-cdk4/6 | 1 |
| 8 | 11,46 | 1 |
| 9 | 0/117 | 1 |
| 10 | 127/168 | 1 |
| 11 | actrn12610000592044\ | 1 |
| 12 | 18t/18a | 1 |
| 13 | dizziness/nausea | 1 |
| 14 | rukararwe-bumetha | 1 |
| 15 | dyslipldaemia | 1 |
| 16 | non-euvolaemia | 1 |
| 17 | hyperadiponectinemia | 1 |
| 18 | ras-mitochondria | 1 |
| 19 | hypogyria | 6 |
| 20 | jouanna | 1 |
| 21 | hecatomb | 1 |
| 22 | difference.laparoscopic | 1 |
| 23 | reimagined | 1 |
| 24 | physiological-based | 1 |
| 25 | 3.83-fold | 1 |
| 26 | pseudo-hyphae | 1 |
| 27 | pre-/post-change | 2 |
| 28 | 18f-fdg-uptake | 1 |
| 29 | carbonitrile | 1 |
| 30 | n-pentane | 1 |
| 31 | htpr-phenotype | 1 |
| 32 | calcaneare | 1 |
| 33 | lncrease | 1 |
| 34 | teambuilding | 1 |
| 35 | digging | 3 |
| 36 | post-handwashing | 1 |
| 37 | action-research | 1 |
| 38 | 3.although | 1 |
| 39 | severeal | 1 |
| 40 | 317.74±60.23mosm | 1 |
| 41 | intestinum | 1 |
| 42 | uv-modification | 1 |
| 43 | immuno-stimulation | 1 |
| 44 | hplc-microfractionation | 1 |
| 45 | decline/deterioration | 1 |
| 46 | c677tmutation | 1 |
| 47 | decurarization | 1 |
| 48 | reduiction | 1 |
| 49 | maternal-reduction | 1 |
| 50 | duringfollow-up | 1 |
| 51 | pvmr | 1 |
| 52 | il13-pe38qqr | 1 |
| 53 | yerberias | 3 |
| 54 | d-ds | 1 |
| 55 | cocaine-choices | 1 |
| 56 | insignificances | 1 |
| 57 | care-aides | 3 |
| 58 | advatages | 1 |
| 59 | 'changes | 3 |
| 60 | immaturities | 1 |
| 61 | 5,5,11,11-tetracyano-5,11-dihydrotetracenes | 1 |
| 62 | estrones | 1 |
| 63 | hyperechoes | 1 |
| 64 | put-analysis | 1 |
| 65 | alrtis | 1 |
| 66 | twis | 4 |
| 67 | 8-14weeks | 1 |
| 68 | key-links | 1 |
| 69 | potassium-channels | 1 |
| 70 | qaly-gains | 2 |
| 71 | mu-modulations | 1 |
| 72 | fa-alterations | 2 |
| 73 | 2pns | 1 |
| 74 | a.marmelos | 1 |
| 75 | gmhsps | 1 |
| 76 | self-repairs | 2 |
| 77 | litigants | 1 |
| 78 | puerperants | 3 |
| 79 | adc-measurements | 1 |
| 80 | improvements | 13,658 |
| 81 | stabilization/improvements | 1 |
| 82 | dysfunctionments | 1 |
| 83 | waypoints | 2 |
| 84 | araneus | 1 |
| 85 | mfus | 1 |
| 86 | cfrct | 1 |
| 87 | increament | 1 |
| 88 | strongpoint | 1 |
| 89 | dysuria-frequency | 1 |
| 90 | perivascularly | 1 |
| 91 | lv-dyssynchrony | 1 |
| 92 | macrosclerotherapy | 1 |
| 93 | fibre-bronchoscopy | 1 |
| 94 | cyanotoxicity | 1 |
| 95 | thirty-day-mortality | 1 |
| 96 | side-effects/mortality | 1 |
| 97 | ag° | 2 |